BEIJING: Clinical trials of the United States biotech company Gilead Sciences’ experimental drug Remdesivir have begun in Wuhan, Hubei province, the centre of the novel coronavirus outbreak.
Experts hope this drug, along with others that have shown to be effective against the virus in test tubes, can also work well in actual human patients.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
